CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer
Authors:
- 11 August 2018
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 71 (11) , 1007-1014
Abstract
Aims In breast cancer models, the functional roles of CD147 in proliferation, invasion and treatment resistance have been widely reported. However, there are only a few studies examining the clinicopathological correlation and prognostic relevance of CD147 in breast cancer, especially in relation to breast cancer molecular subtypes. Methods In this study, we analysed CD147 expression in a large cohort of breast cancers, correlating with clinicopathological features and the expression of a comprehensive panel of biomarkers in triple-negative breast cancer (TNBC) and non-TNBC subsets. Its relationship with patients’ survival was also analysed. Results CD147 was expressed in 11.9%(140/1174) of all cases and in 23.8% (40/168) of TNBC. The expression was associated with tumour histological subtypes (p=0.01) and most commonly seen in carcinoma with medullary features (26.0%). CD147 expression correlated with high tumour grade, presence of necrosis and basal-like breast cancer (BLBC) subtype, high Ki67 and expression of some other basal markers and stem-like markers. CD147 expression was also associated with poor overall survival in chemotherapy treated patients with TNBC. Conclusions CD147 is a putative marker in identifying TNBC or BLBC, and may be useful as a prognosis indicator for patients with TNBC or BLBC post chemotherapy.Keywords
This publication has 32 references indexed in Scilit:
- Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomasBMC Cancer, 2015
- CD1472014
- CD147, CD44, and the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway Cooperate to Regulate Breast Epithelial Cell InvasivenessJournal of Biological Chemistry, 2013
- CD147 mediates chemoresistance in breast cancer via ABCG2 by affecting its cellular localization and dimerizationCancer Letters, 2013
- Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphomaLeukemia, 2011
- HAb18G (CD147), a cancer‐associated biomarker and its role in cancer detectionHistopathology, 2009
- Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma CellsCancer Research, 2009
- Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistanceDrug Resistance Updates, 2008
- Basigin (CD147) Is the Target for Organomercurial Inhibition of Monocarboxylate Transporter Isoforms 1 and 4Journal of Biological Chemistry, 2005
- Emmprin Promotes Anchorage-Independent Growth in Human Mammary Carcinoma Cells by Stimulating Hyaluronan ProductionCancer Research, 2004